Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
Celgene
Celgene
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
NYU Langone Health